Tissue proteomics of the human mammary gland: Towards an abridged definition of the molecular phenotypes underlying epithelial normalcy

Molecular Oncology

Volumn 4, Issue 6, 2010, Pages 539-561

  Moreira, José M A ^a   Cabezón, Teresa ^a   Gromova, Irina ^a   Gromov, Pavel ^a   Timmermans Wielenga, Vera ^a,b   Machado, Isidro ^c   Llombart Bosch, Antonio ^c   Kroman, Niels ^d   Rank, Fritz ^a   Celis, Julio E ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Rigshospitalet   (Denmark)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^d Mental Health Services CPH   (Denmark)

Author keywords

CCL; CK15; DRP3; Normal breast epithelium; Progenitors like cells; Proteomics; UDH

Indexed keywords

BIOLOGICAL MARKER; CELL NUCLEUS RECEPTOR; CYTOKERATIN 15; CYTOKERATIN 19; DIHYDROPYRIMIDINASE; ESTROGEN RECEPTOR ALPHA; ISOPROTEIN; POLYCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ANTIBODY SPECIFICITY; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST LESION; CANCER INVASION; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELL TYPE; DATA BASE; DISEASE COURSE; HIGH RISK BEHAVIOR; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LABORATORY; LACTATION; MAMMARY GLAND; MASS SPECTROMETRY; NIPPLE; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; STEM CELL; WESTERN BLOTTING;

EID: 78349313574     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.09.005     Document Type: Article

References (128)

1. Abdel-Fatah T.M.A., Powe D.G., Hodi Z., Lee A.H.S., Reis-Filho J.S., Ellis I.O. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tumular carcinoma and invasive lobular carcinoma. Am. J. Surg. Pathol. 2007, 31:417-426.
2. Adriance M.C., Inman J.L., Petersen O.W., Bissell M.J. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res. 2005, 7:190-197.
3. SEER Cancer Statistics Review, 1975-2007 2008, National Cancer Institute, Bethesda, MD. S.F. Altekruse, C.L. Kosary, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, J. Ruhl, N. Howlader, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, K. Cronin, H.S. Chen, E.J. Feuer, D.G. Stinchcomb, B.K. Edwards (Eds.).
4. Bánkfalvi A., Ludwig A., De-Hesselle B., Buerger H., Buchwalow I.B., Boecker W. Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases. Mod. Pathol. 2004, 17:1051-1061.
5. Barbareschi M., Pecciarini L., Cangi M.G., Macrì E., Rizzo A., Viale G., Doglioni C. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am. J. Surg. Pathol. 2001, 25:1054-1060.
6. Bartek J., Taylor-Papadimitriou J., Miller N., Millis R. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int. J. Cancer 1985, 36:299-306.
7. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., Mandelblatt J.S., Yakovlev A.Y., Habbema J.D., Feuer E.J. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators: effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 2005, 353:1784-1792.
8. Bini L., Magi B., Marzocchi B., Arcuri F., Tripodi S., Cintorino M., Sanchez J.C., Frutiger S., Hughes G., Pallini V., Hochstrasser D.F., Tosi P. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 1997, 18:2832-2841.
9. Böcker W., Moll R., Poremba C., Holland R., Van Diest P.J., Dervan P., Bürger H., Wai D., Ina Diallo R., Brandt B., Herbst H., Schmidt A., Lerch M.M., Buchwallow I.B. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab. Invest. 2002, 82:737-746.
10. Boecker W., Buerger H., Herbst H., Decker T. Basic principles of precursor lesions of breast cancer. Preneoplasia of the Breast: a New Conceptual Approach to Proliferative Breast Disease 2006, 337-368. Saunders, Munich, Germany. W. Boecker (Ed.).
11. Bohndiek S.E., Brindle K.M. Imaging and 'omic' methods for the molecular diagnosis of cancer. Expert Rev. Mol. Diagn. 2010, 10:417-434.
12. Booth B.W., Boulanger C.A., Smith G.H. Stem cells and the mammary microenvironment. Breast Dis. 2008, 29:57-67.
13. Bray F., McCarron P., Parkin D.M. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004, 6(6):229-239.
14. Brennan D.J., O'Connor D.P., Rexhepaj E., Ponten F., Gallagher W.M. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat. Rev. Cancer 2010, 10:605-617.
15. Burdett E., Kasper F.K., Mikos A.G., Ludwig J.A. Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng. Part B. Rev. 2010, 16:351-359.
16. Celis J.E., Cabezón T., Moreira J.M., Gromov P., Gromova I., Timmermans-Wielenga V., Iwase T., Akiyama F., Honma N., Rank F. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol. Oncol. 2009, 3:220-237.
17. Celis J.E., Gromov P., Cabezón T., Moreira J.M., Ambartsumian N., Sandelin K., Rank F., Gromova I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell. Proteomics 2004, 3:327-344.
18. Celis J.E., Gromov P., Gromova I., Moreira J.M., Cabezón T., Ambartsumian N., Grigorian M., Lukanidin E., Thor Straten P., Guldberg P., Bartkova J., Bartek J., Lukas J., Lukas C., Lykkesfeldt A., Jäättelä M., Roepstorff P., Bolund L., Ørntoft T., Brünner N., Overgaard J., Sandelin K., Blichert-Toft M., Mouridsen H., Rank F.E. Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. Mol. Cell. Proteomics 2003, 2:369-377.
19. Celis J.E., Gromova I., Cabezón T., Gromov P., Shen T., Timmermans-Wielenga V., Rank F., Moreira J.M. Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. Mol. Oncol. 2007, 1:321-349.
20. Celis J.E., Gromova I., Gromov P., Moreira J.M., Cabezón T., Friis E., Rank F. Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. FEBS Lett. 2006, 580:2935-2944.
21. Celis J.E., Moreira J.M., Cabezón T., Gromov P., Friis E., Rank F., Gromova I. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics 2005, 4:492-522.
22. Celis J.E., Moreira J.M., Gromova I., Cabezón T., Gromov P., Shen T., Timmermans V., Rank F. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol. Oncol. 2007, 1:97-119.
23. Celis J.E., Trentemøller S., Gromov P. Gel-based proteomics: high-resolution two-dimensional gel electrophoresis of proteins. Isoelectric Focusing (IEF) and Nonequilibrium pH Gradient Electrophoresis (NEPHGE). Cell Biology. A Laboratory Handbook 2004, vol. 4. Elsevier, San Diego. J.E. Celis, N. Carter, T. Hunter, D. Shotton, K. Simons, J.V. Small (Eds.).
24. Cha S., Imielinski M.B., Rejtar T., Richardson E.A., Thakur D., Sgroi D.C., Karger B.L. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection (LCM)-LC/MS: annotation by protein set enrichment analysis (PSEA) and gene ontology (GO). Mol. Cell. Proteomics 2010, 10.1074/mcp.M110.000398.
25. Charrier E., Reibel S., Rogemond V., Aguera M., Thomasset N., Honnorat J. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol. Neurobiol. 2003, 28:51-64.
26. Cornfield D.B., Palazzo J.P., Schwartz G.F., Goonewardene S.A., Kovatich A.J., Chervoneva I., Hyslop T., Schwarting R. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer 2004, 100:2317-2327.
27. Dabbs D.J., Carter G., Fudge M., Peng Y., Swalsky P., Finkelstein S. Molecular alterations in columnar cell lesions of the breast. Mod. Pathol. 2006, 19:344-349.
28. Deugnier M.A., Teulière J., Faraldo M.M., Thiery J.P., Glukhova M.A. The importance of being a myoepithelial cell. Breast Cancer Res. 2002, 4:224-230.
29. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
30. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998, 351:1451-1467. Early Breast Cancer Trialists' Collaborative Group.
31. Ellis I.O. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod. Pathol. 2010, (23 Suppl. 2):S1-S7.
32. Elston C.W., Ellis I.O. Assessment of histological grade. The Breast 1998, vol. 13:356-384. Churchill Livingstone, Edinburgh/New York. C.W. Elston, I.O. Ellis (Eds.).
33. Engholm G., Ferlay J., Christensen N., Bray F., Gjerstorff M.L., Klint Å, Køtlum J.E., Ólafsdóttir E., Pukkala E., Storm H.H. NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 3.6 2010, Association of the Nordic Cancer Registries/Danish Cancer Society. http://www.ancr.nu.
34. Ernst M.F., Voogd A.C., Coebergh J.W., Roukema J.A. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer 2004, 100:1337-1344.
35. Fass L. Imaging and cancer: a review. Mol. Oncol. 2008, 2:115-152.
36. Fata J.E., Werb Z., Bissell M.J. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res. 2004, 6:1-11.
37. Feeley L., Quinn C.M. Columnar cell lesions of the breast. Histopathology 2008, 52:11-19.
38. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010, 10.1002/ijc.25516.
39. Findeisen P., Neumaier M. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective. Clin. Chem. Lab. Med. 2009, 47:666-684.
40. Fink-Retter A., Czerwenka K., Gschwantler-Kaulich D., Hudelist G., Pischinger K., Manavi M., Kubista E., Singer C.F. Proteomics in mammary cancer research. Eur. J. Gynaecol. Oncol. 2009, 30:635-639.
41. Franzen B., Auer G., Alaiya A.A., Eriksson E., Uryu K., Hirano T., Okuzawa K., Kato H., Linder S. Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors. Int. J. Cancer 1996, 69:408-414.
42. Gaetano C., Matsuo T., Thiele C.J. Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein (hUlip) from neuroblastoma cells. J. Biol. Chem. 1997, 272:12195-12201.
43. Gao X., Pang J., Li L.Y., Liu W.P., Di J.M., Sun Q.P., Fang Y.Q., Liu X.P., Pu X.Y., He D., Li M.T., Su Z.L., Li B.Y. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene 2010, 29:4555-4566.
44. Gast M.C., Schellens J.H., Beijnen J.H. Clinical proteomics in breast cancer: a review. Breast Cancer Res. Treat. 2009, 116:17-29.
45. Goldstein A.S., Huang J., Guo C., Garraway I.P., Witte O.N. Identification of a cell of origin for human prostate cancer. Science 2010, 329:568-571.
46. Goldstein A.S., Stoyanova T., Witte O.N. Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol. Oncol. 2010, 4:385-396.
47. Goldstein N.S., Kestin L.J., Vicini F.A. Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am. J. Clin. Pathol. 2007, 128:1023-1034.
48. Gromov P., Celis J.E., Gromova I., Rank F., Timmermans-Wielenga V., Moreira J.M. A single lysis solution for the analysis of tissue samples by different proteomic technologies. Mol. Oncol. 2008, 2:368-379.
49. Gromov P., Gromova I., Bunkenborg J., Cabezon T., Moreira J.M., Timmermans-Wielenga V., Roepstorff P., Rank F., Celis J.E. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol. Oncol. 2010, 4:65-89.
50. Gromova I., Celis J.E. Protein detection in gels by silver staining: a procedure compatible with mass-spectrometry. Cell Biology. A Laboratory Handbook 2004, vol. 4. Elsevier, San Diego. J.E. Celis, N. Carter, T. Hunter, D. Shotton, K. Simons, J.V. Small (Eds.).
51. Gudjonsson T., Adriance M.C., Sternlicht M.D., Petersen O.W., Bissell M.J. Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia. J. Mammary Gland Biol. Neoplasia 2005, 10:261-272.
52. Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 1996, 180:157-163.
53. Hammond M.E., Hayes D.F., Dowsett M., Allred D.C., Hagerty K.L., Badve S., Fitzgibbons P.L., Francis G., Goldstein N.S., Hayes M., Hicks D.G., Lester S., Love R., Mangu P.B., McShane L., Miller K., Osborne C.K., Paik S., Perlmutter J., Rhodes A., Sasano H., Schwartz J.N., Sweep F.C., Taube S., Torlakovic E.E., Valenstein P., Viale G., Visscher D., Wheeler T., Williams R.B., Wittliff J.L., Wolff A.C. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med. 2010, 134:e48-72. American Society of Clinical Oncology, College of American PathologistsCollege of American Pathologists.
54. Haupt B., Schwartz M.R., Xu Q., Ro J.Y. Columnar cell lesions: a consensus study among pathology trainees. Hum. Pathol. 2010, 41:895-901.
55. Héry C., Ferlay J., Boniol M., Autier P. Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations. Ann. Oncol. 2008, 19:1009-1018.
56. Hiratsuka M., Inoue T., Toda T., Kimura N., Shirayoshi Y., Kamitani H., Watanabe T., Ohama E., Tahimic C.G., Kurimasa A., Oshimura M. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem. Biophys. Res. Commun. 2003, 309:558-566.
57. Hodgson D.R., Whittaker R.D., Herath A., Amakye D., Clack G. Biomarkers in oncology drug development. Mol. Oncol. 2009, 3:24-32.
58. Holdaway I.M., Mason B.H., Kay R.G. Steroid hormone receptors in breast tumours presenting during pregnancy or lactation. J. Surg. Oncol. 1984, 25:38-41.
59. Hynes N.E., Cella N., Wartmann M. Prolactin mediated intracellular signaling in mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 1997, 2:19-27.
60. Jain K.K. Innovations, challenges and future prospects of oncoproteomics. Mol. Oncol. 2008, 2:153-160.
61. Jara-Lazaro A.R., Tse G.M.-K., Tan P.H. Columnar cell lesions of the breast: an update and significance on core biopsy. Pathology 2009, 41:18-27.
62. Jing Y., Xu X.C., Lotan R., Waxman S., Mira-y-Lopez R. Human breast carcinoma slice cultures retain retinoic acid sensitivity. Braz. J. Med. Biol. Res. 1996, 29:1105-1108.
63. Jotwani A.C., Gralow J.R. 2010 Early detection of breast cancer: new biomarker tests on the horizon?. Mol. Diagn. Ther. 2009 Dec 1, 13(6):349-357. 10.2165/11318220-000000000-00000.
64. Karagiannis G.S., Pavlou M.P., Diamandis E.P. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 2010, 4(6):496-510.
65. Kenny P.A., Lee G.Y., Myers C.A., Neve R.M., Semeiks J.R., Spellman P.T., Lorenz K., Lee E.H., Barcellos-Hoff M.H., Petersen O.W., Gray J.W., Bissell M.J. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 2007, 1:84-96.
66. Kim S.Y. A new paradigm for cancer therapeutics development. BMB Rep. 2010, 43:383-388.
67. Kostic C., Shaw P.H. Isolation and characterization of sixteen novel p53 response genes. Oncogene 2000, 19:3978-3987.
68. 2 toxicity. J. Neurochem. 2005, 95:466-474.
69. 2+ channels in NMDA-induced DPYSL3 degradation. Brain Res. 2006, 1119:40-49.
70. Larson P.S., de Las M.A., Cerda S.R. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J. Pathol. 2006, 209:307-316.
71. Leung T., Ng Y., Cheong A., Ng C.H., Tan I., Hall C., Lim L. p80 ROKα binding protein is a novel splice variant of CRMP-1 which associates with CRMP-2 and modulates RhoA-induced neuronal morphology. FEBS Lett. 2002, 532:445-449.
72. Levi F., Lucchini F., Negri E., La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann. Oncol. 2007, 18:593-595.
73. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., Feleppa F., Huschtscha L.I., Thorne H.J., Fox S.B., Yan M., French J.D., Brown M.A., Smyth G.K., Visvader J.E., Lindeman G.J. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913. kConFab.
74. Lopez-Garcia M.A., Geyer F.C., Lacroix-Triki M., Marchió C., Reis-Filho J.S. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 2010, 57:171-192.
75. McCarthy J.R., Bhaumik J., Karver M.R., Sibel Erdem S., Weissleder R. Targeted nanoagents for the detection of cancers. Mol. Oncol. 2010, 4(6):511-528.
76. Miyoshi K., Shillingford J.M., Smith G.H., Grimm S.L., Wagner K.U., Oka T., Rosen J.M., Robinson G.W., Hennighausen L. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J. Cell Biol. 2001, 155:531-542.
77. Moffat D.F., Going J.J. Three dimensional anatomy of complete duct systems in human breast: pathological and developmental implications. J. Clin. Pathol. 1996, 49:48-52.
78. Moll R., Divo M., Langbein L. The human keratins: biology and pathology. Histochem. Cell Biol. 2008, 129:705-733.
79. Molyneux G., Geyer F.C., Magnay F.A., McCarthy A., Kendrick H., Natrajan R., Mackay A., Grigoriadis A., Tutt A., Ashworth A., Reis-Filho J.S., Smalley M.J. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell. 2010, 7:403-417.
80. Mueller C., Liotta L.A., Espina V. Reverse phase protein microarrays advance to use in clinical trials. Mol. Oncol. 2010, 4(6):461-481.
81. Muggerud A.A., Hallett M., Johnsen H., Kleivi K., Zhou W., Tahmasebpoor S., Amini R.M., Botling J., Børresen-Dale A.L., Sørlie T., Wärnberg F. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Mol. Oncol. 2010, 4:357-368.
82. Naor D., Sionov R.V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 1997, 71:241-319.
83. Natali P.G., Nicotra M.R., Sures I., Mottolese M., Botti C., Ullrich A. Breast cancer is associated with loss of the c-kit oncogene product. Int. J. Cancer 1992, 52:713-717.
84. Nelson A.L., Dhimolea E., Reichert J.M. Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 2010, 10.1038/nrd3229.
85. Nofech-Mozes S., Spayne J., Rakovitch E., Hanna W. Prognostic and predictive molecular markers in DCIS: a review. Adv. Anat. Pathol. 2005, 12:256-264.
86. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250:4007-4021.
87. Ohuchi N., Abe R., Takahashi T., Tezuka F. Origin and extension of intraductal papillomas of the breast: a three-dimensional reconstruction study. Breast Cancer Res. Treat. 1984, 4:117-128.
88. Olivotto I.O., Bajdik C.D., Ravdin P.M., Speers C.H., Coldman A.J., Norris B.D., Davis G.J., Chia S.K., Gelmon K.A. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J. Clin. Oncol. 2005, 23:2716-2725.
89. Olsen C.J., Moreira J., Lukanidin E.M., Ambartsumian N.S. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer 2010, 19:444.
90. Parajuli N., Doppler W. Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs. In Vitro Cell Dev. Biol. Anim. 2009, 45:442-450.
91. Pierotti M.A., Negri T., Tamborini E., Perrone F., Pricl S., Pilotti S. Targeted therapies: the rare cancer paradigm. Mol. Oncol. 2010, 4:19-37.
92. Pinder S.E. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. Mod. Pathol. 2010, (23 Suppl. 2):S8-S13.
93. Pinder S.E., Ellis I.O. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)-current definitions and classification. Breast Cancer Res. 2003, 5:254-257.
94. Pinder S.E., Reis-Filho J.S. Non-operative breast pathology: columnar cell lesions. J. Clin. Pathol. 2007, 60:1307-1312.
95. Podo F., Buydens L.M., Degani H., Hilhorst R., Klipp E., Gribbestad I.S., Van Huffel S., van Laarhoven H.W., Luts J., Monleon D., Postma G.J., Schneiderhan-Marra N., Santoro F., Wouters H., Russnes H.G., Sørlie T., Tagliabue E., Børresen-Dale A.L. Triple-negative breast cancer: present challenges and new perspectives. Mol. Oncol. 2010, 4:209-229. FEMME Consortium.
96. Polat A. c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases. Pathol. Res. Pract. 2007, 203:765-769.
97. Quinn C.C., Chen E., Kinjo T.G., Kelly G., Bell A.W., Elliott R.C., McPherson P.S., Hockfield S. TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone. J. Neurosci. 2003, 23:2815-2823.
98. Quinn C.C., Gray G.E., Hockfield S. A family of proteins implicated in axon guidance and outgrowth. J. Neurobiol. 1999, 41:158-164.
99. Riegman P.H., Morente M.M., Betsou F., de Blasio P., Geary P. Biobanking for better healthcare. Mol. Oncol. 2008, 2:213-222. Marble Arch International Working Group on Biobanking for Biomedical Research.
100. Russo J., Balogh G., Russo I.H. Breast cancer prevention. Climacteric 2007, (10 Suppl. 2):47-53.
101. Russo J., Moral R., Balogh G.A., Mailo D., Russo I.H. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005, 7:131-142.
102. Russo J., Russo I.H. Development of the human breast. Maturitas 2004, 49:2-15.
103. Schiess R., Wollscheid B., Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 2009, 3:33-44.
104. Schnitt S.J. Flat epithelial atypia. Preneoplasia of the Breast: a New Conceptual Approach to Proliferative Breast Disease 2006, 369-378. Saunders, Munich, Germany. W. Boecker (Ed.).
105. Schnitt S.J. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia: classification, pathologic features and clinical significance. Breast Cancer Res. 2003, 5:263-268.
106. Schnitt S.J., Vincent-Salomon A. Columnar cell lesions of the breast. Adv. Anat. Pathol. 2003, 10:113-124.
107. Shen Y., Yang Y., Inoue L.Y., Munsell M.F., Miller A.B., Berry D.A. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J. Natl. Cancer Inst. 2005, 97:1195-1203.
108. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
109. Shipitsin M., Campbell L.L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M., et al. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007, 11:259-273.
110. Shoker B.S., Jarvis C., Clarke R.B., Anderson E., Munro C., Davies M.P., Sibson D.R., Sloane J.P. Abnormal regulation of the oestrogen receptor in benign breast lesions. J. Clin. Pathol. 2000, 53:778-783.
111. Simpson J.F. Update on atypical epithelial hyperplasia and ductal carcinoma in situ. Pathology 2009, 41:36-39.
112. Simpson P.T., Gale T., Reis-Filho J.S., Jones C., Parry S., Sloane J.P., Hanby A., Pinder S.E., Lee A.H., Humphreys S., Ellis I.O., Lakhani S.R. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am. J. Surg. Pathol. 2005, 29:734-746.
113. Smith G.H., Chepko G. Mammary epithelial stem cells. Microsc. Res. Tech. 2001, 52:190-203.
114. Stingl J., Eaves C.J., Zandieh I., Emerman J.T. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res. Treat. 2001, 67:93-109.
115. Sugai M., Murata K., Kimura N., Munakata H., Hada R., Kamata Y. Adenoma of the nipple in an adolescent. Breast Cancer 2002, 9:254-256.
116. Tavassoli F.A. Challenges in breast pathology: new twists on old problems. Arch. Pathol. Lab. Med. 2009, 133:852-854.
117. Thorpe S.M. Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. Acta Oncol. 1988, 27:1-19.
118. Toft D.J., Cryns V.L. Minireview: basal-like breast cancer: from molecular profiles to targeted therapies. Mol. Endocrinol. 2010, 10.1210/me.2010-0164.
119. Tremblay G., Deschênes J., Alpert L., Quenneville L.A. Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules. Breast J. 2005, 11:326-332.
120. Tsai Y.C., Lu Y., Nichols P.W., Zlotnikov G., Jones P.A., Smith H.S. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res. 1996, 56:402-404.
121. Vaira V., Fedele G., Pyne S., Fasoli E., Zadra G., Bailey D., Snyder E., Faversani A., Coggi G., Flavin R., Bosari S., Loda M. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8352-8356.
122. van der Kuip H., Mürdter T.E., Sonnenberg M., McClellan M., Gutzeit S., Gerteis A., Simon W., Fritz P., Aulitzky W.E. Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer 2006, 7:86.
123. Villadsen R., Fridriksdottir A.J., Rønnov-Jessen L., Gudjonsson T., Rank F., LaBarge M.A., Bissell M.J., Petersen O.W. Evidence for a stem cell hierarchy in the adult human breast. J. Cell Biol. 2007, 177:87-101.
124. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
125. Visvader J.E., Lindeman G. Stem cells and cancer - the promise and puzzles. Mol. Oncol. 2010, 4:369-372.
126. Wellings S.R., Jensen H.M., Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 1975, 55:231-233.
127. Westbury C.B., Reis-Filho J.S., Dexter T., Mahler-Araujo B., Fenwick K., Iravani M., Grigoriadis A., Parry S., Robertson D., Mackay A., Ashworth A., Yarnold J.R., Isacke C.M. Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation. J. Pathol. 2009, 219:131-140.
128. Wulfkuhle J.D., Sgroi D.C., Krutzsch H., McLean K., McGarvey K., Knowlton M., Chen S., Shu H., Sahin A., Kurek R., Wallwiener D., Merino M.J., Petricoin E.F., Zhao Y., Steeg P.S. Proteomics of human breast ductal carcinoma in situ. Cancer Res. 2002, 62:6740-6749.